1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with dazmegrel in 5 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (dazmegrel) | Trials (dazmegrel) | Recent Studies (post-2010) (dazmegrel) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 207 | 9 | 9 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | dazmegrel (IC50) |
|---|---|---|---|
| Thromboxane-A synthase | Homo sapiens (human) | 0.028 | |
| Thromboxane-A synthase | Rattus norvegicus (Norway rat) | 0.028 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrigón, S; Salinas, P | 1 |
| Barros, EJ; Boim, MA; Braquet, P; dos Santos, OF; Pirotzky, E; Schor, N | 1 |
| Barnes, PJ; Giembycz, MA; Kroegel, C | 1 |
| Apprill, P; Ashton, J; Buja, LM; Campbell, WB; Raheja, S; Schmitz, JM; Tilton, G; Willerson, JT | 1 |
| Chang, SW | 1 |
5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and dazmegrel
| Article | Year |
|---|---|
Protective effects of dazmegrel on the PAF potential of ouabain-induced cardiac arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Disease Models, Animal; Drug Synergism; Female; Guinea Pigs; Imidazoles; Lysine; Ouabain; Platelet Activating Factor; Thromboxane-A Synthase | 1991 |
Nephrotoxicity of cyclosporine: the role of platelet-activating factor and thromboxane.
Topics: Animals; Blood Pressure; Cyclosporine; Glomerular Filtration Rate; Imidazoles; Kidney; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Reference Values; Renal Circulation; Thromboxane A2; Thromboxane-A Synthase | 1991 |
Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins.
Topics: Animals; Azepines; Calcimycin; Calcium; Complement C5a; Cyclooxygenase Inhibitors; Enzyme Activation; Eosinophils; Flurbiprofen; Guinea Pigs; Imidazoles; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandin-Endoperoxide Synthases; Prostaglandins E; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Superoxides; Tetradecanoylphorbol Acetate; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Triazines; Triazoles | 1990 |
Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenergic alpha-Antagonists; Animals; Arteriosclerosis; Coronary Circulation; Coronary Disease; Dogs; Hemodynamics; Imidazoles; Male; Platelet Activating Factor; Platelet Aggregation; Serotonin Antagonists; Thromboxane B2 | 1985 |
TNF potentiates PAF-induced pulmonary vasoconstriction in the rat: role of neutrophils and thromboxane A2.
Topics: Animals; Blood Pressure; Drug Synergism; Imidazoles; In Vitro Techniques; Lipopolysaccharides; Male; Neutropenia; Neutrophils; Platelet Activating Factor; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Thromboxane A2; Thromboxane-A Synthase; Tumor Necrosis Factor-alpha; Vasoconstriction | 1994 |